CINECA IRIS Institutional Research Information System

LISTI', ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 833
EU - Europa 473
AS - Asia 395
AF - Africa 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 827
IT - Italia 223
CN - Cina 159
SG - Singapore 109
IE - Irlanda 94
SE - Svezia 43
VN - Vietnam 35
DE - Germania 26
ID - Indonesia 21
HK - Hong Kong 17
JP - Giappone 14
KR - Corea 14
UA - Ucraina 13
PL - Polonia 12
GB - Regno Unito 11
FR - Francia 9
IN - India 8
NL - Olanda 8
TR - Turchia 6
CA - Canada 5
ES - Italia 5
RU - Federazione Russa 5
FI - Finlandia 4
RO - Romania 4
TW - Taiwan 4
AU - Australia 3
BE - Belgio 3
DK - Danimarca 3
SY - Repubblica araba siriana 3
TG - Togo 3
AT - Austria 2
IR - Iran 2
MK - Macedonia 2
NG - Nigeria 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
CH - Svizzera 1
CO - Colombia 1
HU - Ungheria 1
IQ - Iraq 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 1.713
Salva come PNG Salva come JPEG
Città #
Dublin 93
Santa Clara 89
Singapore 88
Fairfield 84
Chandler 51
Turin 47
Ashburn 45
Beijing 45
Houston 44
Woodbridge 39
Seattle 37
Nyköping 33
Columbus 32
Wilmington 31
Medford 30
Torino 28
Cambridge 25
Dong Ket 25
Princeton 23
Jakarta 20
Hangzhou 16
Ann Arbor 15
Pisa 14
Redwood City 14
Warsaw 12
Dearborn 11
Jacksonville 10
Seoul 10
Nanjing 8
Rome 8
Shanghai 8
Hebei 7
Lusigliè 7
Munich 7
Central District 6
Guangzhou 6
Hefei 6
Hong Kong 6
Milan 6
San Diego 6
Boston 5
Chongqing 5
Norwalk 5
Robbio 5
Tokyo 5
Bologna 4
Chengdu 4
Lasa 4
New York 4
Plymouth Meeting 4
Tianjin 4
Adana 3
Bacoli 3
Brussels 3
Helsinki 3
Leeds 3
Lomé 3
Los Angeles 3
Pittsburgh 3
San Jose 3
Taipei 3
Abuja 2
Assago 2
Barcelona 2
Bari 2
Biella 2
Bitetto 2
Borgomanero 2
Canterbury 2
Catania 2
Chicago 2
Delhi 2
Erlangen 2
Guiyang 2
Harbin 2
Istanbul 2
Kunming 2
Lecce 2
Linden 2
Ludwigshafen 2
Maastricht 2
Napoli 2
Nocera Inferiore 2
Nules 2
Osimo 2
Palermo 2
Paris 2
Pescara 2
Peschiera Borromeo 2
Piemonte 2
Prato 2
Saint-Fons 2
Serrara Fontana 2
Shenzhen 2
Skopje 2
Suzhou 2
Toronto 2
Trieste 2
Upper Marlboro 2
Vienna 2
Totale 1.249
Salva come PNG Salva come JPEG
Nome #
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 114
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients 114
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 94
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.] 92
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations 87
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) 81
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 78
Nintedanib in NSCLC: Evidence to date and place in therapy 78
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 77
Dealing with NSCLC EGFR mutation testing and treatment: a comprehensive review with an Italian real-world perspective 75
Pathological characterization of tumor immune microenvironment (Time) in malignant pleural mesothelioma 75
Repositioning PARP inhibitors in the treatment of thoracic malignancies 74
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non–small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design 73
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer 59
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 58
Diagnostics of BAP1-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience 55
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 49
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas 48
Real-world retrospective study of KRAS mutations in advanced nonsmall cell lung cancer in the era of immunotherapy 43
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity 42
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 41
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment 37
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review 31
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer harboring HRR mutations: interim results of the UNITO-001 phase 2 prospective trial 29
The role of germline mutations in thoracic malignancies: between myth and reality 29
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 24
EGFR inhibition in NSCLC: New findings…. and opened questions? 22
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer 21
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 21
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 19
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 10
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 8
NUPR1 interacts with eIF2aand is required for resolutionof the ER stress response in pancreatic tissue 7
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 6
Totale 1.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020153 0 0 0 0 0 16 22 30 29 26 19 11
2020/2021281 4 16 15 10 26 23 13 23 43 30 27 51
2021/2022351 32 38 27 29 26 20 21 15 13 25 50 55
2022/2023317 30 20 7 24 21 92 32 18 30 5 24 14
2023/2024216 25 32 9 23 4 18 12 12 5 17 25 34
2024/2025341 8 24 37 54 164 54 0 0 0 0 0 0
Totale 1.771